How To Play ITC, PTC India, SBI, Apex Frozen Foods? #AskBQ
AskBQ is BloombergQuint's daily offering where market experts help investors make the right investment choice — be it in equities, commodities or the derivatives markets.
On Wednesday's episode Gaurang Shah, head market strategist at Geojit Financial Services and Sameet Chavan, chief analyst (technical and derivatives) at Angel Broking gave their views on ITC, PTC India, Apex Frozen Foods, SBI and many more.
Watch the full interaction here:
Here are the edited excerpts of the interview:
Riyas Chammayil: Is it the right time to invest in ITC with a six-month-view?
Gaurang Shah: I recommend a buy on ITC. However, the time horizon should be at least one year.
Abhinav Sinha: I bought 150 shares of PTC India at Rs 90.23 apiece with a four-year-view. Can I add more at current levels?
Gaurang Shah: I recommend staying invested. You can also buy more on dips.
Sandeep Joshi: Is it the right time to invest in KEC International with a short-term-view?
Sameet Chavan: I recommend investing in the stock, but not at current levels. Add on dips.
Hari: I bought 500 shares of Apex Frozen Foods at Rs 361 apiece with a long-term view. Should I hold or sell?
Gaurang Shah: I recommend to book a partial profit --25-30 percent -- and diversify into other themes like Indraprastha Gas and Mahanagar Gas.
Akshat Maheshwari: I bought 300 shares of Linde India at Rs 374 with a six-month-view. Should I hold or sell?
Sameet Chavan: I recommend the investor to hold on the stock with a stoploss of Rs 450 on closing basis.
Arpit Maheshwari: I bought 100 shares of CARE Ratings at Rs 1,064 apiece with a four-year-view. What should I do?
Gaurang Shah: I recommend the investor to hold on to the stock.
Balaji Srinivas: Is it the right time to invest in Lupin and Sun Pharma with a long-term view?
Gaurang Shah: I recommend Natco, Aurobindo Pharma, Alkem Laboratories in the pharmaceuticals space with a long-term view.
Akshay: I bought 1,000 shares of NIIT at Rs 93 apiece with a long-term view. Should I hold or sell?
Sameet Chavan: I recommend the investor to maintain his position with a stoploss of Rs 90.
Mohammad: I bought 100 shares of Glenmark Pharma at Rs 710 apiece. What should I do?
Sameet Chavan: I recommend exit at any bounce and invest in Cipla instead.
Ankit Vira: Is it the right time to invest in SBI with a long-term view?
Sameet Chavan: I would recommend the investor to start accumulating in the range of Rs 300-305 levels.
Bhabani Shankar Behera: I bought 2,000 shares of Puravankara at Rs 152 apiece. Should I hold or sell?
Sameet Chavan: With a medium-long term perspective, I advise the investor to remain invested.
Harsh Kothari: What is your view on LT Foods?
Sameet Chavan: I advise the investor to wait for a breakout to happen at Rs 75-76 levels, and on the lower side Rs 68-70 levels would serve as strong support.
Shine Piramal: I bought 100 shares of Federal Reserve at Rs 112 apiece. What should I do?
Gaurang Shah: I recommend to hold the stock with a long-term target of Rs 145-165.
Arpit Maheshwari: I want a long-term view on Welspun India.
Gaurang Shah: I am positive on the stock, but I believe that FMCG, banking, NBFc, auto ancillaries would do better with a long-term perspective.
Here's how you can get your queries answered:
- Tweet us your queries using #AskBQ
- WhatsApp us on +91-8291229686
- Call us on 022-45404141
- Email us on askbq@bloombergquint.com
Analysts' Disclosure: Both the investors do not hold any stock and have no financial interests that were discussed today.
Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.
Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.
BloombergQuint's digital and social media platforms provide views of only SEBI registered investment advisors/analysts.
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.
